Table 4. Gender adjusted Cox hazard ratios and 95% confidence intervals for incident cancer (all locations) according to DBP phenotype groups.
DBP phenotypes | N | HR | 95% CI | |
---|---|---|---|---|
Allele score 0–2 | 0 (1s/1s, 1s/2, 2/2) | 3588 | ref | |
1 (1f/1s, 1f/2) | 1697 | 0.950 | 0.870–1.037 | |
2 (1f/1f) | 242 | 0.767 (P = 0.016) | 0.618–0.951 | |
1f/1f, 1f/1s, 1s/1s | 1s/1s | 1698 | ref | |
1f/1s | 1146 | 0.911 | 0.813–1.020 | |
1f/1f | 242 | 0.766 (P = 0.016) | 0.688–0.852 | |
1f/1f, 1f/2, 2/2 | 2/2 | 342 | ref | |
1f/2 | 551 | 0.986 | 0.805–1.208 | |
1f/1f | 242 | 0.782 | 0.601–1.017 | |
1s/1s, 1s/2, 2/2 | 1s/1s | 1698 | ref | |
1s/2 | 1548 | 0.934 | 0.846–1.041 | |
2/2 | 342 | 0.939 | 0.790–1.116 | |
2/2, 1s/1s, 1f/1f | 2/2 | 342 | ref | |
1s/1s | 1698 | 0.942 | 0.792–1.119 | |
1f/1f | 242 | 0.741 (P = 0.008) | 0.593–0.925 |
The Tromsø study.